Company Profile · Healthcare

Zhangzhou Pientzehuang Pharmaceutical Co Ltd

600436 · Shanghai
Exchange
Shanghai
Country
China
IPO date
May 30, 2003
Employees
2,886
Price at Publication
¥132.59
Aug 15, 2026 close
Fair Buy
≤ ¥90
Margin-of-safety entry
Baillie Growth Score
38/100
Weak
Buffett Score
88/100
Elite
Intrinsic Value · Three-Tier Range Price at publication ¥132.59 · Within the fair intrinsic-value range

Composite valuation range · conservative ¥80–¥90 / fair ¥125–¥165 / optimistic ¥235–¥255. At the publication price of ¥132.59 (Aug 15, 2026), Within the fair intrinsic-value range.

Market capCN¥71.19B
Revenue (TTM)CN¥8.2B
EBITDACN¥1.82B
Profit margin22.08%
ROE11.74%
P/E (TTM)39.33
Forward P/E22.99
EPSCN¥3.00
Dividend yield2.29%
52-week rangeCN¥105.98 – CN¥197.55

Data from EODHD, shown in the reporting currency; for reference only, not investment advice.

Zhangzhou Pientzehuang Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and distributes pharmaceuticals and cosmetics in China and internationally. The company offers traditional Chinese medicines and health products in various forms, including capsule, ointment, tablet, syrup, and pill; health care food and functional drinks; special efficacy cosmetics; and household chemicals under the Pien Tze Huang brand name. It is also involved in the sale of food; production of skin, hair, and oral care daily products; biotechnology and medical device research and development; sale of medical machinery; and online wholesale and retail. The company's products are used for liver diseases, cardiovascular and cerebrovascular, cancer, cold, dermatology, and other applications. It exports its products. The company was founded in 1956 and is based in Zhangzhou, China. Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. operates as a subsidiary of Zhangzhou Jiulongjiang Group Co., Ltd.

History

Coming soonThis section is being filled in — check back soon.

Industry position

Coming soonThis section is being filled in — check back soon.